/ /

  • linkedin
  • Increase Font
  • Sharebar

    Red light technology increases tear break-up time in dry eye patients

    More than 90% of subjects report improvement in symptoms in study

    Take-home message: Treatment with red light technology resulted in a significant improvement in the tear break-up time in the vast majority of patients. This may be a future light treatment for the improvement of dry eye disease in patients with meibomian gland dysfunction.


    Memphis, TN — Red light technology (RLT) may be a future treatment to improve dry eye disease in patients with meibomian gland dysfunction. Application of RLT therapy resulted in improvement in the tear film break-up time in more than 90% of patients with dry eye disease. The results are similar to those reported previously in patients treated with intense pulsed light (IPL) treatment.

    figure 1(Figure 1) Alan G. Kabat, OD, FAAO, performs microblepharoexfoliation on a patient with ocular surface disease using the handheld device. (Photos courtesy of Alan G. Kabat, OD, FAAO)Various light treatment technologies have been used successfully before in other areas of medicine such as dermatology.

    Beginning in 2002, Rolando Toyos, MD, and colleagues noticed that in some of their patients in their Memphis, TN, practice who had undergone application of IPL treatment to skin near the meibomian glands, the function of the glands and their dry eye disease improved.

    This prompted the investigators to later conduct a 3-year retrospective study of IPL treatment of dry eye disease in 91 patients. The therapy consisted of IPL application and gland expression during monthly visits. The results indicated that 87% of patients had improved tear break-up times after seven visits and four maintenance visits; 93% of patients expressed satisfaction with the improved dry eye disease.

    A caveat regarding IPL therapy is that only doctors trained in its application should administer the treatment and special eye shields are needed to avoid ocular damage. The investigators published their findings in the Photomedicine and Laser Surgery (2015; 33:41-46).

    RLT therapy

    Low light-emitting diode RLT therapy using visible light, which was discovered by the National Aeronautics and Space Administration, uses infrared light and, according to Dr. Toyos, also is used for facial rejuvenation. When applied to skin, RLT increases fibroblast activity by increasing the cellular adenosine triphosphate (ATP) activity, which increases elastin and collagen production, he explained. These effects have been documented in numerous studies.

    figure 2(Figure 2) Chronic dry eye symptoms include inflammation of the eyeild margins and inspissation of the meibomian glands. These observations raised the question about whether RLT can be used to treat meibomian gland dysfunction. The investigators theorized that RLT therapy applied close to the eyelid should result in increased cellular ATP activity in the cells of the meibomian gland, including improving the meibomian gland function. In contrast to IPL therapy, RLT is a low-light therapy, and patients can apply the treatment at home.

    When using RLT therapy, Dr. Toyos explained that 600 to 650 nm of visible light is applied to the periorbital skin using a light-emitting diode, generating up to 6 joules/cm.2 The application is done using The Q Device (Quantum Ocular Biosciences) for at least 3 minutes at least twice weekly.



    Rolando Toyos, MD
    Dr. Toyos is in private practice at the Toyos Clinic in Jackson, TN.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results